Published in:
Open Access
01-12-2023 | ECMO | Comment
Beta-blockers in refractory hypoxemia on venovenous extracorporeal membrane oxygenation: a double-edged sword
Authors:
Dawid L. Staudacher, Tobias Wengenmayer, Matthieu Schmidt
Published in:
Critical Care
|
Issue 1/2023
Login to get access
Excerpt
Up to 10% of patients admitted to the intensive care unit (ICU) suffer from acute respiratory distress syndrome (ARDS) [
1]. Severe respiratory failure can result in refractory hypoxemia, characterized by diminished arterial oxygen content and subsequent tissue hypoxia [
2]. To address hypoxia, venovenous extracorporeal membrane oxygenation (V-V ECMO) can be employed, delivering up to 6–7 L per minute of fully oxygenated blood to the venous circulation [
2,
3]. …